-
Overprescribing antibiotics breeds antibiotic resistance. A new tool aims to lower a notably high rate of such prescriptions in Rwanda.
-
When it comes to pregnancy-related depression, how can women and families recognize when the “baby blues” may be something more?
-
The federal government said the state should do more to fight fraud and is holding back funds. Minnesota officials say the attack is unfair as the state's fraud rate is well below national averages.
-
That's how researcher Beatriz Garcia Nice describes the new U.S. stance under the Trump administration to programs addressing gender-based violence.
-
Mifepristone is facing another major legal challenge.
-
A pilot program at the Open Doors transitional home, a Rhode Island not-for-profit, has offered the drugs to 18 of its residents, many of whom say the GLP-1s, along with the other supports offered there, have changed their lives.
-
It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's also beneficial because the HIV virus is always evolving.
-
People are turning to AI chatbots to help them with medical advice. Recent studies suggest these bots are not always helpful in making decisions about health.
-
Outside of Chicago, a homeless shelter and rehab center called Wayside Cross hosts a unique program to help people get back on their feet, one mile at a time.
-
The anti-parasitic drug became a household name during the COVID-19 pandemic, and it is now being embraced as an alternative treatment for cancer. It is as politically polarizing as ever.